Search research articles
Contact Us
Filters
Showing results (1081-1090 of 1,102) with videos related to
Page
of 111
Sort By:
Nature Medicine
|
January 29, 2020
Lentiviral gene therapy for X-linked chronic granulomatous disease
Donald B Kohn, Claire Booth, Elizabeth M Kang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 27, 2021
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
Andrew D Marques, Scott Sherrill-Mix, John Everett, et al.
Nature
|
June 1, 2018
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A Fraietta, Christopher L Nobles, Morgan A Sammons, et al.
Nature Biomedical Engineering
|
March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer
Gregory M Chen, Ankita Jain, David T Gering, et al.
Mbio
|
February 8, 2022
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021
Andrew D Marques, Scott Sherrill-Mix, John K Everett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 13, 2021
Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing
Laura Ford, Christine Lee, Ian W Pray, et al.
Nature Medicine
|
January 9, 2023
Autologous T cell therapy for MAGE-A4<sup>+</sup> solid cancers in HLA-A*02<sup>+</sup> patients: a phase 1 trial
David S Hong, Brian A Van Tine, Swethajit Biswas, et al.
Science (New York, N.Y.)
|
February 8, 2020
CRISPR-engineered T cells in patients with refractory cancer
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Nature Medicine
|
March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Blood
|
January 27, 2026
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory Diarrhea
Viktoria Blumenberg, Filippo Birocchi, Angela Shih, et al.
Page
of 111
Search research articles
Search
Showing results (1081-1090 of 1,102) with videos related to
Sort By:
Page
of 111
Nature Medicine
|
January 29, 2020
Lentiviral gene therapy for X-linked chronic granulomatous disease
Donald B Kohn, Claire Booth, Elizabeth M Kang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 27, 2021
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
Andrew D Marques, Scott Sherrill-Mix, John Everett, et al.
Nature
|
June 1, 2018
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A Fraietta, Christopher L Nobles, Morgan A Sammons, et al.
Nature Biomedical Engineering
|
March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer
Gregory M Chen, Ankita Jain, David T Gering, et al.
Mbio
|
February 8, 2022
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021
Andrew D Marques, Scott Sherrill-Mix, John K Everett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 13, 2021
Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing
Laura Ford, Christine Lee, Ian W Pray, et al.
Nature Medicine
|
January 9, 2023
Autologous T cell therapy for MAGE-A4<sup>+</sup> solid cancers in HLA-A*02<sup>+</sup> patients: a phase 1 trial
David S Hong, Brian A Van Tine, Swethajit Biswas, et al.
Science (New York, N.Y.)
|
February 8, 2020
CRISPR-engineered T cells in patients with refractory cancer
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Nature Medicine
|
March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Blood
|
January 27, 2026
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory Diarrhea
Viktoria Blumenberg, Filippo Birocchi, Angela Shih, et al.
Page
of 111